Skip to ContentSkip to Navigation
About us Latest news News News articles

University of Groningen researcher Jeanine Olsen publishes seagrass genome in Nature

27 January 2016

An international consortium of 35 labs led by University of Groningen Professor of Marine Biology Jeanine Olsen published the genome of the seagrass Zostera marina in the scientific journal Nature on January 27th. Seagrasses are the only flowering plants to have returned to the sea, arguably the most extreme adaptation a terrestrial (or even freshwater) species can undergo. They provide a unique opportunity to study the adaptations involved. The Zostera marina genome is an exceptional resource that supports a wide range of research themes, from the adaptation of marine ecosystems under climate warming and its role in carbon burial to unravelling the mechanisms of salinity tolerance that may further inform the assisted breeding of crop plants.

More information

University of Groningen videos

The weekly online video magazine Unifocus highlights topics related to the University of Groningen in the fields of research and society, student life, teaching, policy and internationalization.
You can find more videos in our video portal.

Last modified:03 March 2025 09.06 a.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 17 July 2025

    Veni-grants for eleven UG researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...

  • 14 July 2025

    ERC Proof of Concept grant for Kottapalli and Covi

    Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).

  • 10 July 2025

    Dutch Research Agenda funding for nanomedicine research

    Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.